Literature DB >> 638167

Lipoprotein lipase of cultured mesenchymal rat heart cells. I. Synthesis, secretion and releasability by heparin.

T Chajek, O Stein, Y Stein.   

Abstract

Cell suspensions prepared from rat hearts were separated by replating into F1, F2 and M cultures, and cultured for 3--11 days. Lipoprotein lipase activity was highest in the F1 cultures which consisted mainly of non-beating, mesenchymal cells. The enzyme activity was released into the medium only after addition of heparin. The release occurred by an initial rapid phase and a continuous slow phase. Both the rapid and the slow release of enzyme activity by heparin were inhibited by about 70% after a 4 h pretreatment with colchicine. Thus, it seems that the vesicular transport is responsible for the translocation of lipoprotein lipase to the cell surface also during the slow process of release. The residual activity in the colchicine treated cultures was higher than in the controls indicating that no inhibition of enzyme synthesis occurred. The slow phase of enzyme release continued also after removal of heparin from the medium but was reduced markedly when protein synthesis was inhibited by cycloheximide. Thus the increase in total enzyme activity encountered after exposure to heparin resulted from stimulation of new enzyme synthesis. The half-time of lipoprotein lipase in the F1 cultures was 35 min and full restoration of enzyme activity was found 60 min after complete removal of cycloheximide from the system. These data indicate that the culture system can be used to study regulation of new enzyme synthesis and its turnover.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638167     DOI: 10.1016/0005-2760(78)90035-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

Review 1.  Regulation of the synthesis, processing and translocation of lipoprotein lipase.

Authors:  J E Braun; D L Severson
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

2.  Short-term incubation of cardiac myocytes with isoprenaline has no effect on heparin-releasable or cellular lipoprotein lipase activity.

Authors:  D L Severson; R Carroll; A Kryski; I Ramírez
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

3.  Effect of taxol on the heparin-induced secretion of lipoprotein lipase from cardiac myocytes.

Authors:  D L Severson; R Carroll
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

4.  Lipoprotein lipase activity in neonatal-rat liver cell types.

Authors:  F Burgaya; J Peinado; S Vilaró; M Llobera; I Ramírez
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

5.  The lipoprotein lipase of white adipose tissue. Changes in the adipocyte cell-surface content of enzyme in response to extracellular effectors in vitro.

Authors:  A A Al-Jafari; A Cryer
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

6.  The storage and synthetic pools of heparin-releasable lipoprotein lipase and hepatic triacylglycerol lipase in the growing puppy.

Authors:  J B Das; I D Joshi; A I Philippart
Journal:  Biochem J       Date:  1982-09-15       Impact factor: 3.857

7.  Established cell lines from rat adipose tissue that secrete lipoprotein lipase.

Authors:  J M Glick; S J Adelman
Journal:  In Vitro       Date:  1983-05

8.  The lipoprotein lipase (clearing-factor lipase) activity of cells isolated from rat cardiac muscle.

Authors:  P Chohan; A Cryer
Journal:  Biochem J       Date:  1978-08-15       Impact factor: 3.857

9.  Lipoprotein lipase activity of rat cardiac muscle. The intracellular distribution of the enzyme between fractions prepared from cardiac muscle and cells isolated from the hearts of fed and starved animals.

Authors:  P Chohan; A Cryer
Journal:  Biochem J       Date:  1979-07-01       Impact factor: 3.857

10.  Secretion of lipoprotein lipase from myocardial cells isolated from adult rat hearts.

Authors:  D L Severson; M Lee; R Carroll
Journal:  Mol Cell Biochem       Date:  1988-01       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.